Cytori CEO Calhoun on Stem Cell Therapies, Contract

Sept. 28 (Bloomberg) -- Christopher Calhoun, chief executive officer of Cytori Therapeutics Inc., talks about the company's $4.7 million contract with the U.S. government to develop a stem cell therapy to treat burns caused by thermal or radioactive bombs. The contract may be worth $106 million over five years if certain milestones are met. Calhoun speaks with Erik Schatzker and Sara Eisen on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Oil in Bear Market: Three Charts That Tell the Story
09:19 - Bloomberg's Alix Steel reports on the price and production of oil. She speaks on "Bloomberg ‹GO›." (Source: Bloomberg)
  • U.S. Economy Expands Less Than Forecast
  • What Went Wrong for Big Oil This Quarter?
  • Citigroup's Buiter on U.S. Economy, Central Banks